Literature DB >> 1652556

Superoxide generation by human neutrophils induced by low doses of Escherichia coli hemolysin.

S Bhakdi1, E Martin.   

Abstract

Escherichia coli hemolysin (Hly) was isolated from bacterial culture supernatants by polyethylene glycol precipitation and centrifugation in glycerol density gradients. The toxin preparations contained less than 1 mol of lipopolysaccharide per 10 mol of protein, and they had no fatty acids. The capacity of purified hemolysin to stimulate superoxide anion production in polymorphonuclear leukocytes was monitored kinetically in a lumimeter by using the lucigenin assay and was correlated with the kinetics of transmembrane pore formation. When applied to leukocytes suspended in protein-free buffer, very low concentrations (0.02 to 0.1 HU/ml) of the toxin strongly stimulated the production of superoxide anions; shortly thereafter, irreversible membrane permeabilization occurred. When the toxin was applied at concentrations exceeding 0.2 to 0.3 HU/ml, membrane permeabilization was so rapid that the cells were unable to mount a respiratory burst. When applied in the narrow range of 0.05 to 0.1 HU/ml, E. coli hemolysin rivaled phorbol myristate acetate in its capacity to stimulate production of superoxide anions. Additionally, hemolysin applied at doses that elicited no pore formation (0.01 to 0.02 HU/ml) primed leukocytes for an augmented response to subsequent challenge by the phorbol ester. These data demonstrate that very low doses of E. coli hemolysin can evoke cellular reactions that appear independent of and precede transmembrane pore formation and cell death.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652556      PMCID: PMC258119          DOI: 10.1128/iai.59.9.2955-2962.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

Review 1.  Secretion of haemolysin by Escherichia coli.

Authors:  N Mackman; J M Nicaud; L Gray; I B Holland
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

2.  Quantitative study of the binding and hemolytic efficiency of Escherichia coli hemolysin.

Authors:  B Eberspächer; F Hugo; S Bhakdi
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

3.  Escherichia coli hemolysin permeabilizes small unilamellar vesicles loaded with calcein by a single-hit mechanism.

Authors:  G Menestrina
Journal:  FEBS Lett       Date:  1988-05-09       Impact factor: 4.124

4.  Mechanism of Escherichia coli alpha-hemolysin-induced injury to isolated renal tubular cells.

Authors:  W F Keane; R Welch; G Gekker; P K Peterson
Journal:  Am J Pathol       Date:  1987-02       Impact factor: 4.307

5.  Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1.

Authors:  R Y Lo; C A Strathdee; P E Shewen
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

6.  Functional similarity between the haemolysins of Escherichia coli and Morganella morganii.

Authors:  B Eberspächer; F Hugo; M Pohl; S Bhakdi
Journal:  J Med Microbiol       Date:  1990-11       Impact factor: 2.472

7.  Bovine pneumonic pasteurellosis: chemiluminescent response of bovine peripheral blood leukocytes to living and killed Pasteurella haemolytica, Pasteurella multocida, and Escherichia coli.

Authors:  Y F Chang; H W Renshaw; J L Augustine
Journal:  Am J Vet Res       Date:  1985-11       Impact factor: 1.156

8.  Alterations of amino acid repeats in the Escherichia coli hemolysin affect cytolytic activity and secretion.

Authors:  T Felmlee; R A Welch
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  Inflammatory lipid mediator generation elicited by viable hemolysin-forming Escherichia coli in lung vasculature.

Authors:  F Grimminger; M Thomas; R Obernitz; D Walmrath; S Bhakdi; W Seeger
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

10.  Staphylococcal alpha toxin promotes blood coagulation via attack on human platelets.

Authors:  S Bhakdi; M Muhly; U Mannhardt; F Hugo; K Klapettek; C Mueller-Eckhardt; L Roka
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

View more
  31 in total

1.  Membrane interaction of Escherichia coli hemolysin: flotation and insertion-dependent labeling by phospholipid vesicles.

Authors:  C Hyland; L Vuillard; C Hughes; V Koronakis
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

2.  Pasteurella haemolytica leukotoxin induces bovine leukocytes to undergo morphologic changes consistent with apoptosis in vitro.

Authors:  P K Stevens; C J Czuprynski
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Role of the lipopolysaccharide-CD14 complex for the activity of hemolysin from uropathogenic Escherichia coli.

Authors:  Lisa E Månsson; Peter Kjäll; Shahaireen Pellett; Gábor Nagy; Rodney A Welch; Fredrik Bäckhed; Teresa Frisan; Agneta Richter-Dahlfors
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

4.  Pro-inflammatory feedback activation cycle evoked by attack of Vibrio cholerae cytolysin on human neutrophil granulocytes.

Authors:  Angela Valeva; Ivan Walev; Silvia Weis; Fatima Boukhallouk; Trudy M Wassenaar; Sucharit Bhakdi
Journal:  Med Microbiol Immunol       Date:  2007-09-20       Impact factor: 3.402

5.  Solid-phase synthesis of lysobactin (katanosin B): insights into structure and function.

Authors:  Edward A Hall; Erkin Kuru; Michael S VanNieuwenhze
Journal:  Org Lett       Date:  2012-05-21       Impact factor: 6.005

Review 6.  Proteinaceous bacterial toxins and pathogenesis of sepsis syndrome and septic shock: the unknown connection.

Authors:  S Bhakdi; F Grimminger; N Suttorp; D Walmrath; W Seeger
Journal:  Med Microbiol Immunol       Date:  1994-07       Impact factor: 3.402

7.  Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide.

Authors:  I Walev; P Vollmer; M Palmer; S Bhakdi; S Rose-John
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

8.  Hemolytically active (acylated) alpha-hemolysin elicits interleukin-1beta (IL-1beta) but augments the lethality of Escherichia coli by an IL-1- and tumor necrosis factor-independent mechanism.

Authors:  T G Gleason; C W Houlgrave; A K May; T D Crabtree; R G Sawyer; W Denham; J G Norman; T L Pruett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  In vivo effects of intravascularly applied Escherichia coli hemolysin: dissociation between induction of granulocytopenia and lethality in monkeys.

Authors:  D Vagts; H P Dienes; P J Barth; H Ronneberger; K D Hungerer; S Bhakdi
Journal:  Med Microbiol Immunol       Date:  1993-03       Impact factor: 3.402

Review 10.  The RTX pore-forming toxin α-hemolysin of uropathogenic Escherichia coli: progress and perspectives.

Authors:  Travis J Wiles; Matthew A Mulvey
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.